Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-25-043973

Chief Financial Officer sold 2,197 shares at $41.23 ($90,582)

  • Chief Financial Officer acquired 6,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Prasad Raju Chief Financial Officer 2025-03-20 Option exercise +6,250 18,964 D
Prasad Raju Chief Financial Officer 2025-03-21 Sale −2,197 $41.23 $90,582 16,767 D
Derivatives
Prasad Raju Chief Financial Officer 2025-03-20 Option exercise · Restricted Stock Units −6,250 18,750 D
Open-market sales · 2,197 sh · avg $41.23 · $90,582
Loading xslF345X05/ownership.xml…